- Home
- EDRY vs TRIB Comparison
EDRY vs TRIB Comparison
Compare EDRY & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- TRIB
- Stock Information
- Founded
- EDRY 2018
- TRIB 1992
- Country
- EDRY Greece
- TRIB Ireland
- Employees
- EDRY N/A
- TRIB N/A
- Industry
- EDRY Marine Transportation
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EDRY Consumer Discretionary
- TRIB Health Care
- Exchange
- EDRY Nasdaq
- TRIB Nasdaq
- Market Cap
- EDRY 31.7M
- TRIB 25.5M
- IPO Year
- EDRY N/A
- TRIB N/A
- Fundamental
- Price
- EDRY $10.48
- TRIB $0.57
- Analyst Decision
- EDRY
- TRIB
- Analyst Count
- EDRY 0
- TRIB 0
- Target Price
- EDRY N/A
- TRIB N/A
- AVG Volume (30 Days)
- EDRY 5.5K
- TRIB 45.4K
- Earning Date
- EDRY 05-20-2025
- TRIB 05-22-2025
- Dividend Yield
- EDRY N/A
- TRIB N/A
- EPS Growth
- EDRY N/A
- TRIB N/A
- EPS
- EDRY N/A
- TRIB N/A
- Revenue
- EDRY $61,083,227.00
- TRIB $59,126,000.00
- Revenue This Year
- EDRY N/A
- TRIB $11.63
- Revenue Next Year
- EDRY $27.93
- TRIB $10.13
- P/E Ratio
- EDRY N/A
- TRIB N/A
- Revenue Growth
- EDRY 28.35
- TRIB N/A
- 52 Week Low
- EDRY $10.04
- TRIB $0.57
- 52 Week High
- EDRY $24.84
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- EDRY 49.71
- TRIB 40.05
- Support Level
- EDRY $10.98
- TRIB $0.57
- Resistance Level
- EDRY $11.38
- TRIB $0.71
- Average True Range (ATR)
- EDRY 0.29
- TRIB 0.04
- MACD
- EDRY 0.01
- TRIB -0.00
- Stochastic Oscillator
- EDRY 29.31
- TRIB 26.60
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.